0000318306-16-000051.txt : 20161215 0000318306-16-000051.hdr.sgml : 20161215 20161215194820 ACCESSION NUMBER: 0000318306-16-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161213 FILED AS OF DATE: 20161215 DATE AS OF CHANGE: 20161215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3333 LEE PARKWAY STREET 2: SUITE 600 CITY: DALLAS STATE: TX ZIP: 75219 BUSINESS PHONE: 2149055100 MAIL ADDRESS: STREET 1: 3333 LEE PARKWAY STREET 2: SUITE 600 CITY: DALLAS STATE: TX ZIP: 75219 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jeffrey B Davis CENTRAL INDEX KEY: 0001349083 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 162054826 BUSINESS ADDRESS: STREET 1: C/O SCO FINANCIAL GROUP LLC STREET 2: 1285 AVENUE OF THE AMERICAS 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-554-4158 MAIL ADDRESS: STREET 1: C/O SCO FINANCIAL GROUP LLC STREET 2: 1285 AVENUE OF THE AMERICAS 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-12-13 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001349083 Jeffrey B Davis 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 1 1 0 0 Chief Operating Officer Stock option (right to buy) 4.45 2016-12-13 4 A 0 37500 0 A 2017-12-13 2026-12-13 Common stock 37500 37500 D Stock option (right to buy) 4.45 2016-12-13 4 A 0 112500 0 A 2018-01-13 2026-12-13 Common stock 112500 150000 D 100% accelerated vesting on change of control. After twelve months from Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. /s/ Jeffrey B. Davis 2016-12-15